Month: August 2025

Aug 31 2025

Uncategorized

Treatment For Psychosis May Be ‘Fundamentally Flawed’, Study Finds – ScienceAlert

by Clinical Editor

No Comments

Treatment For Psychosis May Be ‘Fundamentally Flawed’, Study Finds  ScienceAlert

Aug 31 2025

Uncategorized

Neurodevelopmentally rooted epicenters in schizophrenia: sensorimotor-association spatial axis of cortical thickness alterations – Nature

by Clinical Editor

No Comments

Neurodevelopmentally rooted epicenters in schizophrenia: sensorimotor-association spatial axis of cortical thickness alterations  Nature

Aug 30 2025

Uncategorized

ChatGPT Changes After Teen Suicide; At-Home Igalmi Success; Schizophrenia Rising

by Clinical Editor

No Comments

Artificial intelligence company OpenAI said it’s making changes to ChatGPT following a lawsuit related to a teenager who died by suicide after conversations with the chatbot. ( Bloomberg via MSN)...

Aug 30 2025

Uncategorized

Lithium deficiency may be the hidden spark behind Alzheimer’s

by Clinical Editor

No Comments

Harvard scientists have uncovered that lithium, a naturally occurring element in the brain, may be the missing piece in understanding Alzheimer’s. Their decade-long research shows that lithium depletion—caused by amyloid...

Aug 29 2025

Uncategorized

High-Potency Cannabis Linked to Schizophrenia, Psychosis, and More, Review Finds

by Clinical Editor

No Comments

A systematic review has linked high-concentration THC cannabis products to negative mental health outcomes, particularly psychosis, schizophrenia, and cannabis use disorder. A new systematic review ha …

Aug 29 2025

Uncategorized

Cannabis for coping? Why it may trigger paranoia

by Clinical Editor

No Comments

Using cannabis to self-medicate comes with hidden dangers—new research shows these users face higher paranoia and consume more THC. Childhood trauma further amplifies the risks, especially emotional abuse, which strongly...

Aug 28 2025

Uncategorized

High concentration THC associated with schizophrenia, psychosis and other unfavorable mental health outcomes

by Clinical Editor

No Comments

A systematic review analyzed the associations of high-concentration delta-9-tetrahydrocannabinol (THC) cannabis products with mental health outcomes. The review found that high-concentration THC …

Aug 28 2025

Uncategorized

People with schizophrenia have higher risk of COPD, study says

by Clinical Editor

No Comments

People with schizophrenia are more likely to develop chronic obstructive pulmonary disease (COPD), suggesting a possible syndemic relationship between the two diseases, in addition to people not …

Aug 27 2025

Uncategorized

BioXcel’s agitation drug meets main goal in at-home study

by Clinical Editor

No Comments

BioXcel Therapeutics said on Wednesday its experimental agitation drug met the main goal of a late-stage study testing it in patients with bipolar disorder or schizophrenia for at-home use.

Aug 27 2025

Uncategorized

Focused Group Therapy May Improve Depression and Treatment Compliance in People With Schizophrenia

by Clinical Editor

No Comments

A study of patients with schizophrenia at a psychiatric hospital in China showed that focused group therapy in combination with antipsychotic medication is linked to improvement in depression and …